  Monoclonal antibodies are considered promising therapeutic alternatives to fight antibiotic-resistant bacteria. Upon binding to their targets , they either act alone ( e.g. , by neutralizing bacterial toxins) or in concert with the host 's immune system ( with complement or phagocytes). Storek et al. have described a unique , directly bactericidal antibody against